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Abstract Dental implants are an increasingly popular
solution to missing teeth. Implants are prone to colonisation
by pathogenic oral bacteria which can lead to inflammation,
destruction of bone and ultimately implant failure. The aim
of this study was to investigate the use of chlorhexidine
(CHX) hexametaphosphate (HMP) nanoparticles (NPs)
with a total CHX concentration equivalent to 5 mM as a
coating for dental implants. The CHX HMP NPs had mean
diameter 49 nm and composition was confirmed showing
presence of both chlorine and phosphorus. The NPs formed
micrometer-sized aggregated surface deposits on commer-
cially pure grade II titanium substrates following immer-
sion–coating for 30 s. When CHX HMP NP-coated
titanium specimens were immersed in deionised water,
sustained release of soluble CHX was observed, both in the
absence and presence of a salivary pellicle, for the duration
of the study (99 days) without reaching a plateau. Control
specimens exposed to a solution of aqueous 25 lM CHX
(equivalent to the residual aqueous CHX present with the
NPs) did not exhibit CHX release. CHX HMP NP-coated
surfaces exhibited antimicrobial efficacy against oral pri-
mary colonising bacterium Streptococcus gordonii within
8 h. The antimicrobial efficacy was greater in the presence
of an acquired pellicle which is postulated to be due to
retention of soluble CHX by the pellicle.
1 Introduction
Titanium is the major component of most dental implant
systems, since it exhibits excellent biocompatibility and
supports osseointegration. The rate of osseointegration is
affected by surface roughness; an implant with moderate
roughness of 1–2 lm is thought to be optimal [1]. With
rougher implant surfaces comes an increased susceptibility
to bacterial adhesion, at least in vitro [2–4], and this has
been attributed to increased protection from shear forces
[4]. Drawing inference from such in vitro data, it has been
proposed that rough implant surfaces may exhibit a greater
propensity for implant-associated infections in vivo [5].
Peri-implant mucositis, the most common form of infection,
occurs in approximately 80 % of subjects [6], resulting in
reversible inflammation of peri-implant soft tissues. The
more severe peri-implantitis occurs in about 28–56 % of
subjects [6] and, as well as soft tissue inflammation, results
in loss of the supporting bone. Treatment of peri-implantitis
has unpredictable outcomes and control of plaque in the
mouth surrounding the implant is essential [7].
Upon exposure to the oral cavity, implants, like all
materials, are rapidly coated with a thin proteinaceous film
known as the salivary pellicle. This is composed primarily
of salivary glycoproteins and mediates adhesion of oral
primary colonisers [8]; the most common such species
found on dental implants are the streptococci [9]. Once
adhered, the bacteria proliferate and excrete an extracel-
lular polysaccharide matrix which protects the developing
microcolony. Secondary colonising bacteria then adhere to
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the primary colonisers resulting in biofilm formation. The
microbiota found in infected implant sites have similarities
to those seen in periodontitis [10], although with somewhat
less diversity [11].
Chlorhexidine (CHX) is a broad spectrum antimicrobial
and antifungal agent belonging to the biguanide class of
drugs. It is used extensively in medicine and dentistry, as
the soluble digluconate salt, for a wide range of applica-
tions including mouthrinses, eye drops and as a pre-surgi-
cal topical cleansing agent. Its non-specific mode of action
is associated with rupture of the bacterial cell membrane
resulting in leakage of intracellular components [12]. CHX
adsorbs to titanium oxide surfaces, and the resultant CHX-
coated surface can reduce growth of Streptococcus gor-
donii [13], but the CHX is rapidly depleted providing only
a short-term antimicrobial effect [14].
Antimicrobial nanoparticles (NPs) offer a method for
imparting antimicrobial properties to implant surfaces. One
advantage of NPs as a coating for dental implants when not
embedded in a film but applied directly to the titanium is
that, with careful control of the doping and distribution,
their small size provides the opportunity to leave the
majority of the titanium surface uncoated and thus avail-
able for osteoblast colonisation and subsequent osseointe-
gration. Elemental silver is used as an antimicrobial agent
in many fields of medicine, and silver NPs embedded in
various film coatings have been applied to titanium implant
surfaces for the purpose of conferring antimicrobial activ-
ity [15–19]. However, cytotoxic effects of silver NPs have
been reported and thus safety concerns persist [20, 21].
Chlorhexidine–hexametaphosphate (CHX–HMP) NPs have
recently been reported and act as a slow release device for
soluble CHX [22]. The research question was: do CHX–
HMP NPs have potential as an antimicrobial coating for
titanium dental implants. The hypothesis to be tested was:
CHX–HMP NPs have no antimicrobial efficacy when used
as a coating for titanium.
2 Materials and methods
2.1 Nanoparticle synthesis, specimen preparation
and characterisation
100 mL 10 mM aqueous sodium HMP (Sigma-Aldrich
Company Ltd, Dorset, UK) was added to 100 mL 10 mM
of aqueous CHX digluconate (Sigma-Aldrich Company
Ltd, Dorset, UK) under constant stirring and ambient
conditions. This resulted in a suspension of CHX–HMP
NPs, with a total concentration of 5 mM of both CHX and
HMP.
Approximately 20 lL of NP suspension was deposited
on a 200 mesh carbon-coated copper/gold grid (Agar
Scientific, Essex, UK), left undisturbed for 2 min, then
placed on filter paper to dry. Specimens were imaged using
transmission electron microscopy (TEM; JEM 1200 EX
MKI: Jeol, Welwyn Garden City, UK). In-situ energy-
dispersive X-ray spectroscopy (EDX; ISIS 300: Oxford
Instruments, Bristol, UK) was used to determine the ele-
mental composition of the NP precipitate.
Square sections (10 9 10 9 1 mm) of grade 2 com-
mercially pure titanium (Ti-TEK Ltd, Sutton Coldfield,
UK) were polished using 120 grit silicon carbide paper,
followed by 10 min ultrasonication in acetone and 10 min
ultrasonication in industrial methylated spirits, before
being allowed to dry in air. To coat the titanium specimens
with nanoparticles, individual substrates were suspended in
200 mL of the colloidal suspension for 30 s during rapid
stirring, followed by 10 s immersion in deionised water,
before being blotted to remove excess water and allowed to
dry in air. Selected specimens were coated with gold–
palladium alloy, using a sputter coater (SC7620, Quorum
Technologies, East Grinstead, UK) and imaged using
scanning electron microscopy (SEM) (Phenom, Phenom-
World, Eindhoven, Netherlands).
2.2 CHX elution from CHX–HMP NP coated
titanium
The release of soluble CHX from the CHX–HMP NP
coated specimens was recorded as a function of time. The
experiments were conducted with and without the appli-
cation of a salivary pellicle to the NP-coated titanium, to
determine whether CHX elution was impeded by the
presence of a pellicle. Control groups were titanium sub-
strates treated with deionised water or a 25 lM CHX
solution (the residual CHX concentration in the NP sus-
pension) instead of the NP suspension.
Titanium specimens for elution studies were prepared
and coated with NPs as described above. Control speci-
mens were immersed in deionised water for 40 s (deionised
water controls) or immersed in 25 lM CHX solution for
30 s exposure followed by 10 s in deionised water (aque-
ous CHX controls).
For those specimens to be coated with a salivary pelli-
cle, stimulated saliva was collected from 5 donors (saliva
bank REC reference: 08/H0606/87?5). The saliva was
pooled and 0.02 w/v% sodium azide was added to prevent
bacterial growth. Titanium specimens were incubated, after
coating (with NPs or control treatments), at 37 C for 2 h
in pooled, whole saliva (1 mL/specimen). They were
removed and rinsed in deionised water for 5 min (1 mL/
specimen) immediately prior to elution experiments.
Specimens were placed in UV-transparent cuvettes
(Fisher Scientific, Loughborough, UK), immersed in 3 mL
deionised water and sealed with tight-fitting lids with the
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joint wrapped with Parafilm (Bemis, Londonderry, UK).
Specimens were agitated on an orbital shaker (Stuart-
SSM1; Bibby Scientific Ltd, Stone, UK) at 150 rpm. CHX
concentration was measured periodically by recording
absorbance at 255 nm using a UV spectrophotometer (U-
1900: Hitachi, Tokyo, Japan) and correlating with cali-
bration standards of 5–50 lM CHX [14]. On completion of
elution studies the substrates were removed from the cuv-
ettes, blotted to remove excess water and left to dry in air.
The surfaces were then imaged using SEM.
2.3 Antimicrobial efficacy against Streptococcus
gordonii
Streptococcus gordonii colonisation of titanium substrates
was investigated as a function of NP coating with and
without a salivary pellicle. The proliferation of bacteria in
the media in the well plates was also determined.
Yeast–nitrogen–phosphate–tryptone (YNPT) medium
was prepared by mixing 19 yeast nitrogen base (Appleton
Woods, Birmingham, UK), 0.05 % tryptone (BD, Oxford,
UK) and phosphate buffer, prepared from 10 mM Na2
HPO4 (Fisher Scientific, Loughborough, UK) and KH2PO4
(Sigma-Aldrich, Dorset, UK), pH 7.
Streptococcus gordoniiDL1 cells were grown in screw cap
bottles in 10 mL YNTP medium supplemented with 0.5 mL
of BHY, prepared from Brain Heart Infusion (Lab M Ltd,
Lancashire, UK) and Bacto Yeast Extract (BD, Oxford, UK)
and 10 lLof 40 %aqueous glucose solution (Sigma-Aldrich)
(YNPTG medium) at 37 C, overnight. The resulting culture
was centrifuged and re-suspended in fresh YNTPG medium,
twice. The optical density of the suspension was adjusted to
OD600 = 0.01 (approximately 5 9 10
6 cells/mL).
Saliva from human subjects was collected and stored
under approval from the National Research Ethics Com-
mittee South Central Oxford (# 08/H0606/87?5). Pooled
human saliva from at least six adult subjects, who provided
written informed consent, was mixed with dithiothreitol to
final concentration 2.5 mM, before being centrifuged
(12,000g for 10 min), and re-suspended at 10 % solution
with DI water. The saliva was then filtered through a
0.45 lm filter (Sastedt, Leicester, UK) and stored at
-20 C until required.
NP-coated and uncoated titanium substrates were placed
in a 12-well microtitre plate (Greiner Bio-one, Stonehouse,
UK), immersed in 1 mL of 10 % saliva and incubated at
4 C for 2 h. They were then rinsed in 1 mL phosphate
buffered saline (PBS) (Sigma-Aldrich Company Ltd,
Dorset, UK) for 3 min on a see-saw rocker (StuartSSL4:
Bibby Scientific Ltd, Stone, UK) at 20 rpm, immediately
prior to microbiology assays.
Titanium specimens (NP-coated and uncoated control
samples, with or without an acquired salivary pellicle) were
placed into the wells of 12-well microtitre plates. A 1 mL
aliquot of YNTPG growth medium was added, followed by
the addition of a further 1 mL of bacterial culture. The
specimens were incubated at 37 C while being agitated at
50 rpm. Specimens were removed at times 0, 8, 24, 48 h
and rinsed in fresh YNTPG medium for 3 min on a Stuart
see-saw rocker at 20 rpm before analysis. The experiment
was performed three times with two specimens for each
time point on each occasion, giving a total n = 6 for each
measurement time.
After each titanium specimen was removed and rinsed in
fresh media, they were placed in 1 mL PBS and agitated
using a vortex mixer for 30 s, rested for 3 min, and then
vortex-mixed for a further 30 s. The PBS containing
released bacteria was then serially diluted by 10, 102, 103
and 104 in fresh PBS; 20 lL aliquots of the initial PBS
solution and each dilution were spotted three times onto
dry BHYN plates and incubated overnight. Media from the
wells were also diluted and spotted onto BHYN agar plates
using the same method. The resulting colony forming units
(CFUs) were then counted. In order to assess statistical
significance, a two-way analysis of variance (ANOVA) in
combination with a post hoc Tukey’s range test was per-
formed using SPSS (IBM, Portsmouth, UK). Differences
were deemed significant when P\ 0.05.
2.4 Preparation of specimens for live/dead
fluorescent imaging
Substrates were prepared in the same way as described for
the growth of the S. gordonii on titanium surfaces. Once
rinsed in YNTPG medium, substrates were placed in the
well of a new microtitre plate before being immersed in
fresh YNTPG media containing 3 lL of an equimolar
solution of BacLight SYTO 9 green fluorescent stain and
propidium iodide (Live Technologies, Paisley, UK) before
a 15 min period of dark incubation. The specimens were
then removed from the solution and immediately imaged
using fluorescent optical microscopy (Leica DMLB: Leica
Microsystems, Milton Keynes, UK). The SYTO 9 stain
labelled all bacteria (green) in the population whereas the




Large nanoparticulate aggregates, smaller clusters and
single nanoparticles were observed using TEM (Fig. 1).
EDX data indicated the presence of P, Cl and Na in areas
dense in NPs, as well as Cu and Au which are attributed to
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the TEM grids used as a substrate. Mean NP size was
49.0 nm (SD 13.1 nm) from TEM (n = 62 NPs). Porous
nanoparticle deposits were observed on roughly polised
titanium surfaces (Fig. 2); similar deposits were seen using
atomic force microscopy (data not shown). Surface deposit
was still observed after samples were immersed In deio-
nised water for 95 days (Fig. 2).
3.2 CHX elution from CHX–HMP NP coated
titanium
Soluble CHX was released from CHX–HMP NP-coated
titanium continually throughout the experimental period
(Fig. 3). Approximately 49 more CHX was released from
specimens that were not coated with a salivary pellicle
compared to pellicle-coated specimens. No sustained CHX
release was observed from specimens which had been
immersed in a 25 lM CHX solution.
3.3 Antimicrobial efficacy against Streptococcus
gordonii
The average number of bacteria present in the bacterial
stock solution added to each well was 1.94 9 106 CFU/
mL. S. gordonii CFUs as a function of time on titanium
surfaces and in the wells containing the titanium surfaces
are shown in Fig. 4. S. gordonii CFUs on CHX–HMP NP-
coated titanium without a salivary pellicle decreased as a
function of time, whereas CFUs on the uncoated titanium
increased 103-fold during the first 8 h and then remained
constant. There was no statistically significant difference
between the surfaces at time 0 h (P = 1.000); the differ-
ence between the surfaces was first statistically significant
at time point 8 h (P = 0.01). CFUs in the wells containing
the CHX–HMP NP-coated titanium decreased as a function
of time, whereas CFUs in the uncoated substrate remained
constant. Wells containing no titanium substrate exhibited
very similar CFUs to those containing uncoated titanium
(data not shown). There was no statistically significant
difference between CFUs in the well at time 0 h
(P = 1.000); the difference between the wells was first
statistically significant at time point 24 h (P = 0.001).
Fig. 1 Transmission electron micrographs of CHX–HMP NPs showing single nanoparticles and larger aggregates
cFig. 2 Scanning electron micrographs of uncoated titanium (a, b),
titanium after CHX–HMP NP deposition (c, d), and titanium after
CHX–HMP NP deposition and 95 days’ immersion in deionised
water (e, f)
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In the presence of a salivary pellicle (pellicle applied
after the NP coating but prior to exposure to the bacteria),
the results were broadly similar. CFUs on CHX–HMP NP-
coated titanium decreased over the experimental period and
were reduced to zero by 48 h whereas CFUs on the
uncoated titanium increased 100-fold in the first 8 h then
remained constant. There was no statistically significant
difference between the surfaces at time 0 h (P = 0.979);
the difference between the surfaces was first statistically
significant at time point 8 h (P = 0.002). CFUs in the
wells containing the CHX–HMP NP-coated titanium
decreased with time, reaching zero by 48 h, whereas CFUs
in the uncoated substrate and blank wells remained con-
stant. Wells containing no titanium substrate exhibited very
similar CFUs to those containing uncoated titanium (data
not shown). There was no statistically significant difference
between CFUs in the well at time 0 h (P = 1.000); the
difference between the wells was first statistically signifi-
cant at time point 24 h (P = 0.012).
3.4 Live/dead imaging
There were more live bacteria on uncoated titanium sub-
strates than on NP-coated titanium after 24 and 48 h
(Fig. 5). This was more pronounced in the presence of an
acquired pellicle, where no bacteria were observed on the
NP-coated titanium or in the surrounding media after 48 h.
4 Discussion
NPs with an average size of 49.0 nm (SD: 13.1 nm)
composed of CHX and HMP (indicated by the presence of
Cl and P) formed aggregated NP clusters (Fig. 1). The
presence of Na in the EDX spectrum suggests the persis-
tence of Na from the initial sodium HMP solution, most
likely an artefact of drying the whole NP suspension onto
the TEM grid, which contains all reaction by-products.
Another reason for this could be the electrostatic attraction
between the aqueous Na? ions and the negatively charged
NPs, which have surface charge -50 mV [23].
NP aggregates adhered to titanium specimens immersed
in the NP suspension forming porous micron-sized deposits
surrounded by large regions of what appeared to be bare
titanium (Fig. 2). This rapid attachment to the titanium
surface is postulated to be due to electrostatic attraction
resulting from the highly charged nature of the particles;
this is further supported by the reported deposition of the
same nanoparticles onto a variety of surfaces including
glass and ethylene vinyl acetate (EVA), a widely used
biomedical polymer [22, 23]. Nanoparticle surface deposits
were observed on titanium surfaces after 95 days immer-
sion in deionised water (Fig. 2), but there were fewer of
them compared with freshly coated specimens, which is
thought to be because a proportion of the coating had
dissolved releasing the soluble CHX.
A sustained release of CHX was observed from CHX–
HMP NP-coated titanium without pellicle (Fig. 3). This
compares favourably with other methods to functionalise
materials with CHX, such as a component of a polybenzyl
acrylate [24] or microporous silica [25] coating where the
CHX release decays rapidly over the first hours or days.
CHX was also released by specimens coated with CHX–
HMP NPs and an overlaid salivary pellicle, at a lower rate
and with larger variance in the elution data. It is thought
that the passage of CHX through the pellicle is inhibited
owing to the ability of the salivary pellicle to act as an ion-




























CHX HMP NP coated surface, no
saliva
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Surface exposed to 25µM CHX
Fig. 3 Release of aqueous
CHX from NP-coated titanium
surfaces, with and without a
salivary pellicle, compared with
control samples
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it [26]. It is possible that CHX ions are released from the
NPs but remain localised at the titanium surface and/or
within the pellicle film, which would explain the difference
in antimicrobial activity observed in the presence of a
pellicle.
At t0, there was no significant difference between CFUs
of S. gordonii on specimens coated with CHX–HMP NP
and uncoated surfaces, with and without a salivary pellicle.
More bacteria adhered in the presence of a salivary pellicle,
indicating the mediation of bacterial adhesion afforded by
the proteinaceous film (Fig. 4). After 8 h, CFUs on the
uncoated titanium had increased 1000-fold in the absence
of a pellicle and 100-fold in its presence; the final CFU
reached at 48 h was similar with and without the pellicle.
CFUs remained stable for the NP-coated titanium but
increased for uncoated titanium, both with and without a
pellicle, resulting in a significant difference between the
NP-coated and uncoated substrates across all time points
except t0. In the presence of a pellicle the CFUs on NP-
coated surfaces decreased significantly after 24 h, before
falling again to zero for all specimens. A similar pattern
was seen for the bacteria in the surrounding growth med-
ium; these were reduced in those wells containing NP-
coated specimens but not for those containing uncoated
titanium. The fact that wells containing uncoated titanium
and empty wells exhibited very similar numbers of bacteria
indicates that the titanium per se did not affect bacterial
growth in the medium. The main difference afforded by the
pellicle was that viable S. gordonii were reduced in the
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Fig. 4 S. gordonii CFUs (a) on
titanium surfaces and (b) in
wells containing titanium
surfaces, as a function of time,
with error bars indicating
standard deviations
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pellicle, both on surfaces and in the medium, which sug-
gests that active CHX was sequestered in the pellicle layer
and thus offered a more concentrated source of antimi-
crobial for these specimens.
These observations are largely corroborated by the
findings of the optical microscopy using a live/dead stain.
A reduction in live bacteria was observed on the NP-coated
surfaces after 24 and 48 h, compared with uncoated sur-
faces (Fig. 5). The presence of some live bacteria on the
NP-coated surfaces after 48 h, when no CFUs could be
retrieved, suggests that the CHX NPs were in this case
offering a bacteriostatic rather than bactericidal effect. The
small, but statistically significant, reduction in CFU num-
ber for the uncoated and blank wells after 24 and 48 h is
hypothesised to be due to the reduction of nutrients in the
media caused by the metabolic action of the bacteria.
Since twice-daily CHX application in situ reduced pla-
que formation on titanium abutments in the mouth [27], a
means to apply CHX for a sustained period without regular
intervention, and/or for those areas which are not accessi-
ble to a mouth rinse or other product, could have a bene-
ficial effect with regard to biofilm formation. A randomized
multi-centre clinical trial indicated that multiple applica-
tions of chlorhexidine chips over 18 weeks resulted in
substantial improvement in sites with peri-implantitis,
indicating that a local environment with a sustained pres-
ence of chlorhexidine was clinically beneficial in infected
sites [28].
The antimicrobial efficacy demonstrated here can be
expected to be sustained only as long as there remain
CHX–HMP NPs to deliver soluble CHX. Since the release
mechanism relies on dissolution, this will be inherently
limited by the maximum NP coverage that can be applied
while still allowing effective osteoblast colonisation and
maturation and production of bone. The dissipation of
CHX from the implant site is likely to be slower in vivo
than in the experimental model reported here where the
specimens are immersed in water and vigorously agitated.
Irrespective, since the primary risk period for colonisation
of the implant surface with microbes is during or soon after
implant placement [9], and CHX offers effective treatment
of peri-implant mucositis [29], a coating which could
deliver CHX for weeks or months after surgery may be of
utility even if the effect is not indefinite.
5 Conclusions
CHX–HMP NPs were used to create a porous aggregating
coating on titanium surfaces. This coating released soluble
CHX continually over the duration of the study. Growth of
S. gordonii was reduced on the NP-coated surfaces com-
pared to uncoated titanium and titanium exposed to an
aqueous solution of CHX. With further optimisation, this
technology may find application in the prevention and/or
treatment of peri-implant infection.
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